Llwytho...
Naming Convention, Interchangeability, and Patient Interest in Biosimilars
Although biosimilars may offer cost savings over their comparable biologics, use of biosimilars in the United States remains relatively low. This study investigates two barriers to uptake of biosimilars in the United States. First, the U.S. Food and Drug Administration requires that four-letter suff...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Diabetes Spectr |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Diabetes Association
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7428664/ https://ncbi.nlm.nih.gov/pubmed/32848349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/ds19-0065 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|